

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34539647 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.34539647 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97972442 |
| 4 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.52351137 |
| 5 | hypotonic response (GO:0006971) | 3.42119807 |
| 6 | detection of other organism (GO:0098543) | 3.40353770 |
| 7 | detection of bacterium (GO:0016045) | 3.28282009 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25185681 |
| 9 | positive regulation of histone deacetylation (GO:0031065) | 3.15447225 |
| 10 | apoptotic cell clearance (GO:0043277) | 3.14544681 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13985540 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.13985540 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13985540 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13985540 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13985540 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.13985540 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.11234787 |
| 18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08398107 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08283681 |
| 20 | cellular extravasation (GO:0045123) | 3.03082378 |
| 21 | response to laminar fluid shear stress (GO:0034616) | 2.98950416 |
| 22 | detection of external biotic stimulus (GO:0098581) | 2.94020822 |
| 23 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92405318 |
| 24 | positive regulation of p38MAPK cascade (GO:1900745) | 2.91777023 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91381381 |
| 26 | positive regulation of receptor recycling (GO:0001921) | 2.89766306 |
| 27 | response to muramyl dipeptide (GO:0032495) | 2.88501811 |
| 28 | regulation of necroptotic process (GO:0060544) | 2.87575623 |
| 29 | leukocyte aggregation (GO:0070486) | 2.87404403 |
| 30 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.85702038 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 2.84490516 |
| 32 | activation of Rac GTPase activity (GO:0032863) | 2.84288369 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 2.83936672 |
| 34 | cell adhesion mediated by integrin (GO:0033627) | 2.82782470 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 2.81115517 |
| 36 | COPI coating of Golgi vesicle (GO:0048205) | 2.81115517 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80765547 |
| 38 | negative regulation of granulocyte differentiation (GO:0030853) | 2.80676835 |
| 39 | low-density lipoprotein particle clearance (GO:0034383) | 2.79284630 |
| 40 | regulation of extracellular matrix disassembly (GO:0010715) | 2.78098867 |
| 41 | membrane raft organization (GO:0031579) | 2.74277563 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73674947 |
| 43 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.71808739 |
| 44 | regulation of cholesterol storage (GO:0010885) | 2.70157543 |
| 45 | negative regulation of necroptotic process (GO:0060546) | 2.68742715 |
| 46 | morphogenesis of an endothelium (GO:0003159) | 2.67169891 |
| 47 | endothelial tube morphogenesis (GO:0061154) | 2.67169891 |
| 48 | hemidesmosome assembly (GO:0031581) | 2.65689032 |
| 49 | regulation of p38MAPK cascade (GO:1900744) | 2.63758796 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62900792 |
| 51 | substrate-dependent cell migration (GO:0006929) | 2.59861840 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55505431 |
| 53 | detection of biotic stimulus (GO:0009595) | 2.54454705 |
| 54 | defense response to fungus (GO:0050832) | 2.54076455 |
| 55 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.52484072 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51068586 |
| 57 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50838243 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50601226 |
| 59 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.50386152 |
| 60 | response to interleukin-15 (GO:0070672) | 2.50317831 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 2.49923261 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49903568 |
| 63 | regulation of mast cell degranulation (GO:0043304) | 2.49880907 |
| 64 | response to fungus (GO:0009620) | 2.49572524 |
| 65 | protein localization to endosome (GO:0036010) | 2.49204070 |
| 66 | germ cell migration (GO:0008354) | 2.49138634 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 2.47958998 |
| 68 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.47299597 |
| 69 | mannose metabolic process (GO:0006013) | 2.46705207 |
| 70 | regulation of defense response to virus by virus (GO:0050690) | 2.46587805 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 2.46350046 |
| 72 | endodermal cell differentiation (GO:0035987) | 2.45827003 |
| 73 | pinocytosis (GO:0006907) | 2.45590686 |
| 74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43637912 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42942120 |
| 76 | germinal center formation (GO:0002467) | 2.42878621 |
| 77 | positive regulation of lamellipodium assembly (GO:0010592) | 2.42218603 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 2.41550271 |
| 79 | response to peptidoglycan (GO:0032494) | 2.41090722 |
| 80 | desmosome organization (GO:0002934) | 2.40602693 |
| 81 | establishment of endothelial barrier (GO:0061028) | 2.40387314 |
| 82 | embryonic process involved in female pregnancy (GO:0060136) | 2.40312258 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.40271666 |
| 84 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.40248053 |
| 85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39968745 |
| 86 | natural killer cell differentiation (GO:0001779) | 2.39343116 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 2.38663582 |
| 88 | epithelial cell-cell adhesion (GO:0090136) | 2.38450011 |
| 89 | leukocyte cell-cell adhesion (GO:0007159) | 2.38435249 |
| 90 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36854889 |
| 91 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.36083400 |
| 92 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.35600717 |
| 93 | hepatocyte apoptotic process (GO:0097284) | 2.35323873 |
| 94 | pentose-phosphate shunt (GO:0006098) | 2.35110080 |
| 95 | mesodermal cell differentiation (GO:0048333) | 2.34288436 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 2.34204446 |
| 97 | * cell-substrate junction assembly (GO:0007044) | 2.33597179 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 2.32317699 |
| 99 | positive regulation of lamellipodium organization (GO:1902745) | 2.31994057 |
| 100 | basement membrane organization (GO:0071711) | 2.31522252 |
| 101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.31400388 |
| 102 | response to host (GO:0075136) | 2.31400388 |
| 103 | response to host defenses (GO:0052200) | 2.31400388 |
| 104 | regulation of necrotic cell death (GO:0010939) | 2.31207340 |
| 105 | response to fluid shear stress (GO:0034405) | 2.30854891 |
| 106 | * adherens junction assembly (GO:0034333) | 2.30395927 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.29842383 |
| 108 | positive regulation of protein deacetylation (GO:0090312) | 2.29329055 |
| 109 | regulation of regulated secretory pathway (GO:1903305) | 2.28554080 |
| 110 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.28454721 |
| 111 | positive thymic T cell selection (GO:0045059) | 2.28314311 |
| 112 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.28310406 |
| 113 | modulation by symbiont of host cellular process (GO:0044068) | 2.28280684 |
| 114 | * cell-substrate adherens junction assembly (GO:0007045) | 2.28075597 |
| 115 | * focal adhesion assembly (GO:0048041) | 2.28075597 |
| 116 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.28043317 |
| 117 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.27051384 |
| 118 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.26511035 |
| 119 | negative regulation of cell size (GO:0045792) | 2.26406539 |
| 120 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26153079 |
| 121 | negative regulation of viral release from host cell (GO:1902187) | 2.26059286 |
| 122 | regulation of tolerance induction (GO:0002643) | 2.25884673 |
| 123 | response to type I interferon (GO:0034340) | 2.25265451 |
| 124 | neutrophil activation (GO:0042119) | 2.24757154 |
| 125 | maternal placenta development (GO:0001893) | 2.24686374 |
| 126 | positive regulation of B cell differentiation (GO:0045579) | 2.24661432 |
| 127 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.24533036 |
| 128 | semaphorin-plexin signaling pathway (GO:0071526) | 2.24499030 |
| 129 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.24347973 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.24072310 |
| 131 | regulation of integrin activation (GO:0033623) | 2.23984744 |
| 132 | regulation of macrophage cytokine production (GO:0010935) | 2.22469638 |
| 133 | * integrin-mediated signaling pathway (GO:0007229) | 2.21057640 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.20941609 |
| 135 | positive regulation of interferon-alpha production (GO:0032727) | 2.19946349 |
| 136 | negative regulation of cell killing (GO:0031342) | 2.19754870 |
| 137 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.19754870 |
| 138 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.18594783 |
| 139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.18022626 |
| 140 | response to host immune response (GO:0052572) | 2.18022626 |
| 141 | granulocyte activation (GO:0036230) | 2.17950945 |
| 142 | negative regulation of fatty acid transport (GO:2000192) | 2.17563724 |
| 143 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.17202511 |
| 144 | skin morphogenesis (GO:0043589) | 2.16637268 |
| 145 | cortical actin cytoskeleton organization (GO:0030866) | 2.16576395 |
| 146 | striated muscle atrophy (GO:0014891) | 2.16238608 |
| 147 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.14885530 |
| 148 | negative regulation of stress fiber assembly (GO:0051497) | 2.11351002 |
| 149 | apoptotic process involved in morphogenesis (GO:0060561) | 2.10782491 |
| 150 | stress fiber assembly (GO:0043149) | 2.10604777 |
| 151 | phospholipid homeostasis (GO:0055091) | 2.10505828 |
| 152 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.10158392 |
| 153 | regulation of interferon-alpha production (GO:0032647) | 2.08915383 |
| 154 | negative regulation of heart growth (GO:0061117) | 2.07534148 |
| 155 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.07534148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.50874776 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40406572 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07860316 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.82834427 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81786252 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51508384 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.46831845 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43704704 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.39179702 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33987621 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.26020932 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24533301 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.24161190 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22781720 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22752429 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16439199 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16404350 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16392611 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15072594 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14977910 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.13907822 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06734844 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06675650 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.04191284 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03451610 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03036722 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.96549796 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92844210 |
| 29 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91930242 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91797622 |
| 31 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89891750 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85187338 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84004908 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78976338 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76833520 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75392733 |
| 37 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.69916773 |
| 38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69786691 |
| 39 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67941446 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67915373 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67845070 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61745862 |
| 43 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61740902 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.56758511 |
| 45 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56400556 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54439649 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53462353 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52059713 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49529486 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48970696 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48949430 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46598254 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.45509288 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42951725 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42346204 |
| 56 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41897751 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41043838 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40250306 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40194795 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.37280724 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33608171 |
| 62 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33605246 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31199845 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30728875 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28688964 |
| 66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.27635171 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24182181 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23971407 |
| 69 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22482041 |
| 70 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22406344 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22224538 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22041152 |
| 73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21978508 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21645738 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20700823 |
| 76 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20512132 |
| 77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20301259 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19921321 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18997890 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18955292 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18783786 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18622724 |
| 83 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18597311 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18565118 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18565118 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18326860 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16709399 |
| 88 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.16258058 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16123937 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15773597 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14641524 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14466699 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14423163 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13967314 |
| 95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13358257 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13309720 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13164698 |
| 98 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13051226 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12821705 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11982804 |
| 101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11174159 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11154025 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.10333338 |
| 104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10145691 |
| 105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09823011 |
| 106 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09605638 |
| 107 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09455015 |
| 108 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07122868 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06453900 |
| 110 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06171140 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05848615 |
| 112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.05743571 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05346735 |
| 114 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.04580617 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04513374 |
| 116 | * P68_20966046_ChIP-Seq_HELA_Human | 1.04310087 |
| 117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04231150 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03251064 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02942819 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02184650 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02180987 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02001644 |
| 123 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01154978 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98166870 |
| 125 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97535627 |
| 126 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97535627 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96741458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.16133027 |
| 2 | MP0003300_gastrointestinal_ulcer | 2.91447444 |
| 3 | MP0003303_peritoneal_inflammation | 2.81659790 |
| 4 | MP0009278_abnormal_bone_marrow | 2.67873362 |
| 5 | MP0003436_decreased_susceptibility_to | 2.41942557 |
| 6 | MP0005451_abnormal_body_composition | 2.41890652 |
| 7 | MP0008260_abnormal_autophagy | 2.40135514 |
| 8 | MP0003566_abnormal_cell_adhesion | 2.16272182 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.07779527 |
| 10 | MP0000685_abnormal_immune_system | 1.93003827 |
| 11 | MP0005076_abnormal_cell_differentiation | 1.89173369 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 1.89083348 |
| 13 | MP0004858_abnormal_nervous_system | 1.86816598 |
| 14 | MP0001835_abnormal_antigen_presentation | 1.83583553 |
| 15 | MP0004510_myositis | 1.82836191 |
| 16 | MP0009840_abnormal_foam_cell | 1.80607257 |
| 17 | MP0005360_urolithiasis | 1.64802335 |
| 18 | MP0005058_abnormal_lysosome_morphology | 1.63550842 |
| 19 | MP0002419_abnormal_innate_immunity | 1.62385512 |
| 20 | MP0009785_altered_susceptibility_to | 1.58247408 |
| 21 | MP0004947_skin_inflammation | 1.58223601 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.56244113 |
| 23 | MP0005023_abnormal_wound_healing | 1.55090719 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.54914083 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.54492390 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.53360869 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.53360869 |
| 28 | MP0003279_aneurysm | 1.52828856 |
| 29 | MP0001958_emphysema | 1.52717514 |
| 30 | MP0005387_immune_system_phenotype | 1.51845720 |
| 31 | MP0001790_abnormal_immune_system | 1.51845720 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.49464387 |
| 33 | MP0000343_altered_response_to | 1.49460267 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.49305479 |
| 35 | MP0005025_abnormal_response_to | 1.47540551 |
| 36 | MP0003045_fibrosis | 1.46393754 |
| 37 | MP0002796_impaired_skin_barrier | 1.45383403 |
| 38 | MP0005409_darkened_coat_color | 1.44675370 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.44282304 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.44119175 |
| 41 | MP0002060_abnormal_skin_morphology | 1.43670256 |
| 42 | MP0000733_abnormal_muscle_development | 1.42510829 |
| 43 | MP0003724_increased_susceptibility_to | 1.42116196 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.42048809 |
| 45 | MP0003828_pulmonary_edema | 1.37494443 |
| 46 | MP0002405_respiratory_system_inflammati | 1.36323769 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.36237646 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.35440426 |
| 49 | MP0005164_abnormal_response_to | 1.35086912 |
| 50 | MP0001800_abnormal_humoral_immune | 1.34223247 |
| 51 | MP0001853_heart_inflammation | 1.33625146 |
| 52 | MP0001873_stomach_inflammation | 1.33151828 |
| 53 | MP0000751_myopathy | 1.32805465 |
| 54 | MP0004272_abnormal_basement_membrane | 1.32694163 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.32579148 |
| 56 | MP0003448_altered_tumor_morphology | 1.24894733 |
| 57 | MP0006054_spinal_hemorrhage | 1.23562789 |
| 58 | MP0003091_abnormal_cell_migration | 1.23528576 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.23293812 |
| 60 | MP0004381_abnormal_hair_follicle | 1.22746070 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.22350298 |
| 62 | MP0001819_abnormal_immune_cell | 1.19574172 |
| 63 | MP0004233_abnormal_muscle_weight | 1.18998410 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.18843846 |
| 65 | MP0002723_abnormal_immune_serum | 1.18339921 |
| 66 | MP0010307_abnormal_tumor_latency | 1.17586015 |
| 67 | MP0004883_abnormal_blood_vessel | 1.16820880 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.16425452 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.16213114 |
| 70 | MP0006082_CNS_inflammation | 1.16178000 |
| 71 | MP0000858_altered_metastatic_potential | 1.14165809 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.13395685 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.10942605 |
| 74 | MP0000767_abnormal_smooth_muscle | 1.10181087 |
| 75 | MP0002132_abnormal_respiratory_system | 1.10146070 |
| 76 | MP0005390_skeleton_phenotype | 1.08760148 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 1.07985450 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.07484905 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.07263419 |
| 80 | MP0003075_altered_response_to | 1.03498995 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 1.01608462 |
| 82 | MP0010630_abnormal_cardiac_muscle | 1.01409868 |
| 83 | MP0005671_abnormal_response_to | 1.01199884 |
| 84 | MP0002933_joint_inflammation | 1.00899628 |
| 85 | MP0001851_eye_inflammation | 1.00783449 |
| 86 | MP0002006_tumorigenesis | 0.99990766 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.99733675 |
| 88 | MP0002398_abnormal_bone_marrow | 0.99641438 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.99619158 |
| 90 | MP0003252_abnormal_bile_duct | 0.99176868 |
| 91 | MP0005501_abnormal_skin_physiology | 0.98790961 |
| 92 | MP0001849_ear_inflammation | 0.98731768 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.98014466 |
| 94 | MP0004084_abnormal_cardiac_muscle | 0.97228525 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.97161209 |
| 96 | MP0000716_abnormal_immune_system | 0.97064509 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.96239349 |
| 98 | MP0004087_abnormal_muscle_fiber | 0.95114085 |
| 99 | MP0008469_abnormal_protein_level | 0.94819040 |
| 100 | MP0000609_abnormal_liver_physiology | 0.91817759 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.90345083 |
| 102 | MP0009764_decreased_sensitivity_to | 0.90283909 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.88966747 |
| 104 | MP0000249_abnormal_blood_vessel | 0.88291318 |
| 105 | MP0002722_abnormal_immune_system | 0.87127837 |
| 106 | MP0001542_abnormal_bone_strength | 0.87096840 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 0.86795775 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.86729740 |
| 109 | MP0003866_abnormal_defecation | 0.86383820 |
| 110 | MP0002429_abnormal_blood_cell | 0.85763189 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.85740611 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.85444033 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.85058128 |
| 114 | MP0001915_intracranial_hemorrhage | 0.85012725 |
| 115 | MP0000490_abnormal_crypts_of | 0.84792780 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.84370902 |
| 117 | MP0005275_abnormal_skin_tensile | 0.83406425 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.83094537 |
| 119 | MP0005621_abnormal_cell_physiology | 0.83039247 |
| 120 | MP0005166_decreased_susceptibility_to | 0.83025398 |
| 121 | MP0005083_abnormal_biliary_tract | 0.82282028 |
| 122 | MP0009053_abnormal_anal_canal | 0.81722935 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.81278454 |
| 124 | MP0003795_abnormal_bone_structure | 0.81259894 |
| 125 | MP0000749_muscle_degeneration | 0.80513664 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.80155102 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.80009365 |
| 128 | MP0002139_abnormal_hepatobiliary_system | 0.79340623 |
| 129 | MP0003763_abnormal_thymus_physiology | 0.77358082 |
| 130 | MP0004130_abnormal_muscle_cell | 0.76844905 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.75946372 |
| 132 | MP0002254_reproductive_system_inflammat | 0.74671163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.85193259 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.49369807 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.14530081 |
| 4 | Distal lower limb muscle weakness (HP:0009053) | 3.07572013 |
| 5 | Interstitial pulmonary disease (HP:0006530) | 2.99009261 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 2.90270181 |
| 7 | Distal lower limb amyotrophy (HP:0008944) | 2.90029538 |
| 8 | Hematochezia (HP:0002573) | 2.88648712 |
| 9 | Broad face (HP:0000283) | 2.86528984 |
| 10 | Spontaneous hematomas (HP:0007420) | 2.76423411 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73612378 |
| 12 | Arterial tortuosity (HP:0005116) | 2.72944141 |
| 13 | Fragile skin (HP:0001030) | 2.70360735 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 2.69368769 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 2.61836538 |
| 16 | Vascular tortuosity (HP:0004948) | 2.61422214 |
| 17 | Increased connective tissue (HP:0009025) | 2.60866546 |
| 18 | Vertebral compression fractures (HP:0002953) | 2.56225652 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50821877 |
| 20 | Aortic aneurysm (HP:0004942) | 2.49532727 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.46532170 |
| 22 | Protrusio acetabuli (HP:0003179) | 2.46186226 |
| 23 | Myositis (HP:0100614) | 2.45908911 |
| 24 | Obstructive sleep apnea (HP:0002870) | 2.42748900 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41022058 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.41022058 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.40462683 |
| 28 | Ulnar deviation of the wrist (HP:0003049) | 2.37591587 |
| 29 | Polycythemia (HP:0001901) | 2.31793434 |
| 30 | Myocardial infarction (HP:0001658) | 2.31772749 |
| 31 | Pustule (HP:0200039) | 2.30695321 |
| 32 | Spinal rigidity (HP:0003306) | 2.28947820 |
| 33 | Esophageal varix (HP:0002040) | 2.28613219 |
| 34 | Nasal polyposis (HP:0100582) | 2.27457573 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.27435000 |
| 36 | Increased density of long bones (HP:0006392) | 2.27153591 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.27000894 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.25489517 |
| 39 | Peritonitis (HP:0002586) | 2.24142415 |
| 40 | Cellulitis (HP:0100658) | 2.23996328 |
| 41 | Lymphangioma (HP:0100764) | 2.23693025 |
| 42 | Upper limb amyotrophy (HP:0009129) | 2.22216982 |
| 43 | Distal upper limb amyotrophy (HP:0007149) | 2.22216982 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.20452209 |
| 45 | Shallow orbits (HP:0000586) | 2.16212167 |
| 46 | Colitis (HP:0002583) | 2.15895761 |
| 47 | Aneurysm (HP:0002617) | 2.15555032 |
| 48 | Gingivitis (HP:0000230) | 2.15117629 |
| 49 | Type 1 muscle fiber predominance (HP:0003803) | 2.14846164 |
| 50 | Hand muscle atrophy (HP:0009130) | 2.14828758 |
| 51 | Mitral valve prolapse (HP:0001634) | 2.14763861 |
| 52 | Short nail (HP:0001799) | 2.14057981 |
| 53 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.13731281 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.13470715 |
| 55 | Broad metatarsal (HP:0001783) | 2.12964320 |
| 56 | Amyloidosis (HP:0011034) | 2.11245340 |
| 57 | Arterial thrombosis (HP:0004420) | 2.10845150 |
| 58 | Periodontitis (HP:0000704) | 2.10584345 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.09879902 |
| 60 | Thin bony cortex (HP:0002753) | 2.09077134 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.08509617 |
| 62 | Aortic dissection (HP:0002647) | 2.07556363 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06647252 |
| 64 | Impaired platelet aggregation (HP:0003540) | 2.06409609 |
| 65 | Abnormal platelet function (HP:0011869) | 2.06409609 |
| 66 | Cervical subluxation (HP:0003308) | 2.05682291 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.02945467 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.02662223 |
| 69 | Orchitis (HP:0100796) | 2.02417573 |
| 70 | Easy fatigability (HP:0003388) | 2.01803893 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01387743 |
| 72 | Nephritis (HP:0000123) | 1.99824693 |
| 73 | Atrophic scars (HP:0001075) | 1.99758851 |
| 74 | Ulnar bowing (HP:0003031) | 1.99566030 |
| 75 | Ankle contracture (HP:0006466) | 1.97867521 |
| 76 | Thick nail (HP:0001805) | 1.96608651 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 1.96191791 |
| 78 | Hyperacusis (HP:0010780) | 1.96048995 |
| 79 | Spondylolisthesis (HP:0003302) | 1.96040570 |
| 80 | Frequent falls (HP:0002359) | 1.95506533 |
| 81 | Blue sclerae (HP:0000592) | 1.95155252 |
| 82 | Subacute progressive viral hepatitis (HP:0006572) | 1.94152662 |
| 83 | Achilles tendon contracture (HP:0001771) | 1.93827807 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 1.93269898 |
| 85 | Milia (HP:0001056) | 1.89734463 |
| 86 | Chest pain (HP:0100749) | 1.89403518 |
| 87 | Disproportionate tall stature (HP:0001519) | 1.89187264 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.88383832 |
| 89 | Spinal cord lesions (HP:0100561) | 1.88309171 |
| 90 | Syringomyelia (HP:0003396) | 1.88309171 |
| 91 | Nail dystrophy (HP:0008404) | 1.87351859 |
| 92 | Abnormality of oral frenula (HP:0000190) | 1.87163942 |
| 93 | Chronic otitis media (HP:0000389) | 1.86367054 |
| 94 | Abnormal vertebral ossification (HP:0100569) | 1.85760629 |
| 95 | Hyporeflexia of lower limbs (HP:0002600) | 1.85513626 |
| 96 | Muscle fiber splitting (HP:0003555) | 1.84769839 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.83878768 |
| 98 | Recurrent viral infections (HP:0004429) | 1.83799775 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 1.83639791 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.82685350 |
| 101 | Difficulty running (HP:0009046) | 1.81718819 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81340835 |
| 103 | Mucopolysacchariduria (HP:0008155) | 1.81340835 |
| 104 | Obstructive lung disease (HP:0006536) | 1.80879425 |
| 105 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80879425 |
| 106 | Exercise-induced muscle cramps (HP:0003710) | 1.80763673 |
| 107 | Difficulty climbing stairs (HP:0003551) | 1.80380224 |
| 108 | Mitral regurgitation (HP:0001653) | 1.79679124 |
| 109 | Dilatation of the ascending aorta (HP:0005111) | 1.78762918 |
| 110 | Rectal prolapse (HP:0002035) | 1.78161319 |
| 111 | Slender build (HP:0001533) | 1.77717437 |
| 112 | Generalized amyotrophy (HP:0003700) | 1.77270607 |
| 113 | Dysostosis multiplex (HP:0000943) | 1.76154696 |
| 114 | Ankyloglossia (HP:0010296) | 1.75597104 |
| 115 | Trismus (HP:0000211) | 1.75244854 |
| 116 | Abnormality of the fingertips (HP:0001211) | 1.74728614 |
| 117 | Recurrent skin infections (HP:0001581) | 1.74691004 |
| 118 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74263546 |
| 119 | Retrobulbar optic neuritis (HP:0100654) | 1.73166371 |
| 120 | Optic neuritis (HP:0100653) | 1.73166371 |
| 121 | Increased mean platelet volume (HP:0011877) | 1.72427894 |
| 122 | Prolonged bleeding time (HP:0003010) | 1.71744851 |
| 123 | Flat acetabular roof (HP:0003180) | 1.71582079 |
| 124 | Genu recurvatum (HP:0002816) | 1.71509886 |
| 125 | Wormian bones (HP:0002645) | 1.69807164 |
| 126 | Hypertriglyceridemia (HP:0002155) | 1.69747314 |
| 127 | Long palpebral fissure (HP:0000637) | 1.69663560 |
| 128 | Complement deficiency (HP:0004431) | 1.69634826 |
| 129 | Bicuspid aortic valve (HP:0001647) | 1.69575037 |
| 130 | Abnormality of complement system (HP:0005339) | 1.69112421 |
| 131 | Urticaria (HP:0001025) | 1.67828955 |
| 132 | Metaphyseal cupping (HP:0003021) | 1.67679286 |
| 133 | Fatigue (HP:0012378) | 1.67045288 |
| 134 | Gingival bleeding (HP:0000225) | 1.66278103 |
| 135 | Premature rupture of membranes (HP:0001788) | 1.66033068 |
| 136 | Axonal loss (HP:0003447) | 1.65820483 |
| 137 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65539016 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.65165710 |
| 139 | Persistence of primary teeth (HP:0006335) | 1.64559234 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64043762 |
| 141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64043762 |
| 142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64043762 |
| 143 | Glomerulonephritis (HP:0000099) | 1.63649393 |
| 144 | Ventricular tachycardia (HP:0004756) | 1.62983421 |
| 145 | Hemorrhage of the eye (HP:0011885) | 1.62982778 |
| 146 | Increased IgE level (HP:0003212) | 1.62953396 |
| 147 | Fragile nails (HP:0001808) | 1.62785853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.31890111 |
| 2 | ERN1 | 3.53010693 |
| 3 | PKN2 | 3.20426626 |
| 4 | EEF2K | 2.73944330 |
| 5 | TTN | 2.73593319 |
| 6 | RIPK1 | 2.62012431 |
| 7 | PRPF4B | 2.50213619 |
| 8 | MST1R | 2.48175572 |
| 9 | MAP4K1 | 2.44226143 |
| 10 | MAP3K10 | 2.30118466 |
| 11 | TGFBR2 | 2.27459632 |
| 12 | SMG1 | 2.23981377 |
| 13 | STK10 | 2.02348779 |
| 14 | MAP2K3 | 1.89333326 |
| 15 | TYK2 | 1.85919110 |
| 16 | LRRK2 | 1.83550089 |
| 17 | TBK1 | 1.69457061 |
| 18 | SIK1 | 1.69183129 |
| 19 | * PTK6 | 1.68075999 |
| 20 | CDK12 | 1.65433223 |
| 21 | FGFR4 | 1.64558140 |
| 22 | SIK3 | 1.59952160 |
| 23 | PRKD2 | 1.56745348 |
| 24 | LMTK2 | 1.50326708 |
| 25 | KDR | 1.47584404 |
| 26 | MET | 1.38548817 |
| 27 | JAK3 | 1.37444380 |
| 28 | BMX | 1.34809645 |
| 29 | MAP3K13 | 1.33695212 |
| 30 | ZAP70 | 1.33575533 |
| 31 | KSR2 | 1.32407769 |
| 32 | TESK2 | 1.30173674 |
| 33 | MAP3K14 | 1.28765131 |
| 34 | DMPK | 1.27554065 |
| 35 | JAK1 | 1.27451956 |
| 36 | STK38 | 1.25111689 |
| 37 | TIE1 | 1.24047300 |
| 38 | GRK6 | 1.21271140 |
| 39 | MAP3K1 | 1.19850108 |
| 40 | TAOK2 | 1.19321074 |
| 41 | TRPM7 | 1.18229446 |
| 42 | MAP3K3 | 1.17381508 |
| 43 | CAMK1D | 1.15488390 |
| 44 | CDC42BPA | 1.09358133 |
| 45 | KIT | 1.09348060 |
| 46 | PDGFRA | 1.06881001 |
| 47 | RPS6KA4 | 1.06094405 |
| 48 | CSF1R | 1.04684008 |
| 49 | CDK6 | 1.04404288 |
| 50 | MARK2 | 1.04142834 |
| 51 | FGFR3 | 1.04080875 |
| 52 | MOS | 1.02778603 |
| 53 | MAP3K6 | 1.02776594 |
| 54 | BLK | 1.01348076 |
| 55 | ICK | 1.00162637 |
| 56 | HCK | 0.99409844 |
| 57 | IKBKE | 0.98777045 |
| 58 | CHUK | 0.97610556 |
| 59 | NME2 | 0.94535529 |
| 60 | TNK2 | 0.94031710 |
| 61 | MAP3K11 | 0.93163966 |
| 62 | IRAK4 | 0.92548364 |
| 63 | PDPK1 | 0.91151848 |
| 64 | CAMK1G | 0.89772136 |
| 65 | * CSK | 0.88116990 |
| 66 | FES | 0.87923139 |
| 67 | MAP3K7 | 0.87101268 |
| 68 | ITK | 0.84748884 |
| 69 | JAK2 | 0.83852170 |
| 70 | FLT3 | 0.83840202 |
| 71 | TGFBR1 | 0.83418292 |
| 72 | MTOR | 0.81753491 |
| 73 | NEK9 | 0.80051101 |
| 74 | STK3 | 0.79768395 |
| 75 | TAOK3 | 0.79260454 |
| 76 | FGR | 0.77793358 |
| 77 | IKBKB | 0.77033376 |
| 78 | * BTK | 0.76870904 |
| 79 | PRKG2 | 0.75953675 |
| 80 | NTRK1 | 0.75922821 |
| 81 | EPHA3 | 0.75701787 |
| 82 | PIM1 | 0.75490596 |
| 83 | ARAF | 0.74570951 |
| 84 | MAP3K2 | 0.73354047 |
| 85 | MAP3K8 | 0.73173730 |
| 86 | LATS1 | 0.72046965 |
| 87 | SCYL2 | 0.71735525 |
| 88 | EPHA2 | 0.71516234 |
| 89 | SIK2 | 0.70052752 |
| 90 | ALK | 0.68977387 |
| 91 | ERBB4 | 0.68664213 |
| 92 | TAOK1 | 0.68377110 |
| 93 | PAK2 | 0.68276997 |
| 94 | PDGFRB | 0.68065035 |
| 95 | IRAK2 | 0.65505197 |
| 96 | HIPK2 | 0.65150032 |
| 97 | CDK4 | 0.64417280 |
| 98 | TESK1 | 0.63204242 |
| 99 | * PAK4 | 0.63018220 |
| 100 | NEK2 | 0.62058568 |
| 101 | MATK | 0.61628171 |
| 102 | MAPKAPK3 | 0.60404964 |
| 103 | * PTK2 | 0.60335421 |
| 104 | RPS6KB2 | 0.58279724 |
| 105 | DDR2 | 0.57662490 |
| 106 | MAP2K2 | 0.56969383 |
| 107 | LIMK1 | 0.56908286 |
| 108 | RPS6KA6 | 0.56517008 |
| 109 | PDK1 | 0.56294188 |
| 110 | MARK3 | 0.56239650 |
| 111 | ILK | 0.55401408 |
| 112 | YES1 | 0.54524499 |
| 113 | MYLK | 0.54404581 |
| 114 | IRAK3 | 0.54391797 |
| 115 | LCK | 0.53928511 |
| 116 | MAPKAPK2 | 0.53557873 |
| 117 | PIK3CG | 0.52437847 |
| 118 | RPS6KL1 | 0.52165442 |
| 119 | RPS6KC1 | 0.52165442 |
| 120 | RET | 0.51180737 |
| 121 | CLK1 | 0.50707834 |
| 122 | MAPK11 | 0.50156990 |
| 123 | KSR1 | 0.49118602 |
| 124 | DYRK1B | 0.48844243 |
| 125 | EGFR | 0.48755636 |
| 126 | ROCK2 | 0.48568325 |
| 127 | RPS6KA2 | 0.47083819 |
| 128 | PRKAA2 | 0.46656595 |
| 129 | MELK | 0.46639680 |
| 130 | CDK9 | 0.45710109 |
| 131 | MAPK7 | 0.45444291 |
| 132 | RPS6KA1 | 0.44414110 |
| 133 | PRKD1 | 0.42846801 |
| 134 | SGK3 | 0.42359500 |
| 135 | EPHB2 | 0.41686751 |
| 136 | TEC | 0.41080602 |
| 137 | RIPK4 | 0.40371488 |
| 138 | LATS2 | 0.40158811 |
| 139 | MAPK12 | 0.39246407 |
| 140 | IRAK1 | 0.37119144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40908099 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19196346 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00938045 |
| 4 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.83404393 |
| 5 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.74037351 |
| 6 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64464671 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58829403 |
| 8 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.57798743 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56847013 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44793222 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43720266 |
| 12 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42994967 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42885954 |
| 14 | Amoebiasis_Homo sapiens_hsa05146 | 1.42191856 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39950010 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37833517 |
| 17 | * Focal adhesion_Homo sapiens_hsa04510 | 1.36675430 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35959270 |
| 19 | Thyroid cancer_Homo sapiens_hsa05216 | 1.35586607 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32487845 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.30500462 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.29706226 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.29364689 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28800969 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.28074369 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.26536568 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.23539067 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.23414068 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22585940 |
| 30 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.20172455 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18948356 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.17858833 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.17315731 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.17160307 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17109869 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17013150 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15675448 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.15601467 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15267996 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.12776452 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.06948583 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06922825 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.05781212 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05597190 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05314099 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05244131 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04887272 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.04555675 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03573374 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02252277 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.00432144 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99166407 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97553224 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96722854 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.94844704 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92040043 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91375091 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90963850 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89992346 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89678019 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89487460 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.89077894 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.86165757 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85675593 |
| 65 | Prostate cancer_Homo sapiens_hsa05215 | 0.85428452 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85222158 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84733379 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83770400 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83762824 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83167462 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82475317 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82418825 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80628842 |
| 74 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80372352 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80263336 |
| 76 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80042177 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79373132 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79151480 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77980149 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77839774 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77737866 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.77707386 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77335335 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.77147652 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76759934 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75648272 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75072127 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74545041 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73969917 |
| 90 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73897319 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73889922 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73601134 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73508115 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.72677959 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71194421 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70766568 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70739590 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69689001 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69650739 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69562742 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69535572 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.69333539 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68808788 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67237254 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66033003 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65980502 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64785672 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64742301 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62205006 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.61700856 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59253111 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.58815630 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58402098 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58041628 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58024761 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58017765 |
| 117 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57675876 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57651814 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.55705233 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55567955 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55544277 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52855321 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52389709 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50735877 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49501250 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47985828 |

